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Abstract
Background: The ubiquity of smartphones and health apps make them a potential self-management tool for patients that could
be prescribed by medical professionals. However, little is known about how Australian general practitioners and their patients
view the possibility of prescribing mobile health (mHealth) apps as a nondrug intervention.
Objective: This study aimed to determine barriers and facilitators to prescribing mHealth apps in Australian general practice
from the perspective of general practitioners and their patients.
Methods: We conducted semistructured interviews in Australian general practice settings with purposively sampled general
practitioners and patients. The audio-recorded interviews were transcribed, coded, and thematically analyzed by two researchers.
Results: Interview participants included 20 general practitioners and 15 adult patients. General practitioners’ perceived barriers
to prescribing apps included a generational difference in the digital propensity for providers and patients; lack of knowledge of
prescribable apps and trustworthy sources to access them; the time commitment required of providers and patients to learn and
use the apps; and concerns about privacy, safety, and trustworthiness of health apps. General practitioners perceived facilitators
as trustworthy sources to access prescribable apps and information, and younger generation and widespread smartphone ownership.
For patients, the main barriers were older age and usability of mHealth apps. Patients were not concerned about privacy and data
safety issues regarding health app use. Facilitators for patients included the ubiquity of smartphones and apps, especially for the
younger generation and recommendation of apps by doctors. We identified evidence of effectiveness as an independent theme
from both the provider and patient perspectives.
Conclusions: mHealth app prescription appears to be feasible in general practice. The barriers and facilitators identified by the
providers and patients overlapped, though privacy was of less concern to patients. The involvement of health professionals and
patients is vital for the successful integration of effective, evidence-based mHealth apps with clinical practice.
(JMIR Mhealth Uhealth 2020;8(7):e17447) doi: 10.2196/17447
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Introduction
The number of smartphones and mobile health (mHealth) apps
has risen globally, with Australians at the forefront with
smartphone ownership near 90% of the population [1]. In
addition to fitness and wellness, mHealth apps are primarily
created for and can benefit patients in managing chronic diseases
[2]. More than half of US consumers have downloaded at least
one mHealth app [3]. Despite the high initial uptake of apps,
user retention rates can be low, and the duration of app usage
can be short [4,5]. However, according to AppScript, an app
prescription platform, prescribed mHealth apps have a higher
retention rate than nonprescribed apps [2].
Health professionals prescribe mHealth apps in their practice
in varying degrees [6-9]. Although relevant professional
organizations provide some guidance on how to prescribe
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mHealth technology in clinical practice, health professionals
are often left to navigate this new area on their own [10-12]. A
systematic review by Gagnon et al [13] identified about 180
individual barriers and facilitators to adoption of mHealth by
health professionals, about third of which reflect factors directly
relevant to their knowledge, attitude toward, and acceptance of
mHealth. However, these findings were not specific to general
practice.
In Australia, the Royal Australian College of General
Practitioners (RACGP) offers limited guidance on mHealth
apps. The college also has been collecting basic data on
providers’ app usage as part of their Annual Technology survey
[14]. However, the survey has not explored potential barriers
to mHealth app adoption in-depth. It is essential to explore the
issues around app prescription in general practice in order to
devise effective interventions to overcome the barriers perceived
by the practitioners. Therefore, the objectives of this study were
to determine the barriers to and facilitators of the prescription
of mHealth apps in Australian general practice from the
perspectives of general practitioners and their patients.
Methods
Participants
We conducted one-to-one semistructured interviews with 20
Australian general practitioners (GPs; 8 via telephone and 12
face-to-face) and 15 patients (all face-to-face) in South East
Queensland (Australia) general practices between July and
December 2017. We recruited the participants using purposive
sampling to ensure a diverse range of years of experience and
age. Recruitment was done mainly through snowballing via
colleagues, organizational contacts, and via initial participants.
Participation in the interviews was voluntary and written
informed consent was obtained from each participant before
the interview. GPs were interviewed in their consultation rooms
or over the phone. Patients were interviewed in the waiting area
of the clinic if privacy was ensured.
Procedure
We chose semistructured interviews as they allow for flexibility
to explore a new subject yet are structured enough to achieve
the study aim. The interview questions were developed by the
authors, piloted with three academic GPs, and revised before
the study. The questions were designed to explore participants’
attitudes toward smartphone health apps, their thoughts on the
possibility of prescribing health apps, and perceived potential
barriers and facilitators to prescribing apps in general practice
consultations (Figure 1). Toward the end of the interview,
participants were shown (or in the case of phone interviews,
apps were named) 9 examples of popular Health & Fitness and
Medical apps from the major app stores and 9 examples of tested
and effected apps identified through our earlier study on the
evidence supporting health and medical apps in order to gauge
their general familiarity with mHealth apps [15] (Figure 2). No
financial or other incentives were offered to participants.
Figure 1. Guide map for the interview.
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Figure 2. Example apps are shown to interviewees to identify their familiarity with evidence-based vs. popular mHealth apps.
Data Analysis
We planned to interview 15-20 GPs and a similar number of
patients. Data saturation was fully achieved, ie, no new content
emerged after 3 consecutive interviews in both cohorts by the
time we interviewed 20 GPs and 15 patients, therefore validating
that our sample size was sufficient. All interviews were
conducted, audio-recorded, and transcribed verbatim by the first
author (OB).
We employed a thematic analysis methodology described by
Braun and Clarke [16]. The six phases of analysis were
familiarization with the data, coding, generating initial themes,
reviewing themes, defining and naming themes, and report
writing. Two researchers (OB, RS) familiarized themselves
with the interview transcripts and independently coded them.
Partially inductive thematic analysis was carried out, and
generated themes were reviewed in consultation with the third
author (TH). The results are written up by the first author (OB).
We used the Consolidated Criteria for Reporting Qualitative
Research checklist to report the details of our study [17], which
is provided as Multimedia Appendix 1. Ethics approval was
obtained from the Bond University Human Research Ethics
Committee (16016).
Results
We interviewed 20 general practitioners and 15 patients, the
demographics of whom are shown in Table 1. Ten additional
patients declined to be interviewed, citing that they have never
used mHealth apps or do not know anything about them. None
of the providers we approached declined to be interviewed.
Interviews averaged about four minutes for patients and twelve
minutes for GPs.
Table 1. Participant characteristics.
Total, n (%)Group
General practitioners (n=20)
Years in practice
6 (30)<10
6 (30)10-20
8 (40)>20
12 (60)Gender (female)
Patients (n=15)
Age (years)
5 (33.3)18-35
5 (33.3)36-50
5 (33.3)Over 50
10 (66.6)Gender (female)
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General Practitioners’ Perspectives
The majority of the GPs reported using health apps personally,
professionally, and recommending health apps to patients.
However, most GPs suggest apps mostly in generic terms in
areas such as mindfulness and period-tracking without naming
specific apps and let patients make the final choice because they
do not know any specific vetted and safe apps.
The GPs were more familiar with popular apps such as
MyFitnessPal, Headspace, and Smiling Mind than
evidence-based apps. None of the GPs was familiar with five
of the evidence-based apps (SuperBetter, MyMealMate,
AccupedoPro, Vegethon, Tat). Sources for finding health apps
to recommend varied from trusted websites and medical
publications to word-of-mouth and app stores.
About half of the participants were unfamiliar with the
Handbook of Non-Drug Interventions (HANDI) web resource
from the RACGP [18], but upon being introduced to it, they all
agreed that HANDI would be a trustworthy resource for
evidence-based apps, consistent with those GPs who were
already familiar with HANDI.
Barriers
We identified four themes around barriers to app prescription
in general practice. The most prominent barrier cited was a
generational difference in the overall digital propensity for both
doctors and their patients.
Most patients who would benefit from them are elderly
and they don’t do apps. They don’t do smartphones.
That’s the number one barrier. And most of our
patients who are over 70 will be in that category.
Most I would say. [GP7]
Well, it’s probably my age group more than anything.
it’s just I’m not as familiar with and as happy around
technology as the newer doctors… I do feel it’s
important to try to learn it because it’s part of the
future… so it’s that technology I think is the main
barrier as far as being used to it. I think we need to
but it’s just hard to do. Can we get away with it? I
guess that’s what’s happening to a lot of older doctors
is seeing if we really need to do it or not. [GP5]
GPs with more than 20 years of experience appeared more likely
to find mHealth apps a “gimmick” and less likely to consider
using them in their practice.
I think it would be [possible to prescribe apps]. The
trouble is I think they’re a bit of a gimmick. I mean
we’ve always had accessories to health. When I was
a young doctor people would bring in their calendars
which showed when their next periods are. Now they
pull out their phones… you find the phone is slower
than the calendar because the calendar… is there
and you’d be able to see it visually, whereas a phone,
they’re pulling it out… trying to find it miss it… then
the reception is not good and it takes ages for it to
download. So I don’t really find them a step forward.
They probably are for the person using them at home.
But in the consultation, they’re often not a step
forward I find. [GP9]
GPs who primarily work with elderly patients would not
consider using apps as potential interventions. The “cut-off age”
for recommending apps to patients was around 40-60 years.
For somebody like me, there will be obstacles because
I don’t really use apps. So, if you’re not comfortable
with that sort of things yourself, you have to overcome
that to recommend it... Even when I’ve learned about
them in an education session, I always forget what
they are, because I don’t use them… In fact, the only
times I ever recommend apps at all are for young
people… they don’t have to be young-young, even in
their 30s, a young professional… But I never
recommend to people older than that. So, there is
obviously a generational issue. [GP3]
However, exceptions to the age-based generalization were
commonly mentioned, making individual digital propensity a
more influential factor than age in deciding to prescribe apps.
I got some elderly patients that don’t use an iPhone
too often or an app. But there’s a lot of savvy oldies
there too. It probably depends on the patient, their
interests. [GP11]
GPs also recognize that age is a transient barrier as the younger
cohort of patients will age and become patients with chronic
diseases.
It is a very good idea and something that can be very
useful. But I never know which ones are good to use
and which population would be good to use them. I’m
sure it will come especially as right now the younger
population are the ones who are really into the
smartphones and they’ll get older and have chronic
medical conditions in the next 20 years I’m sure it
will there’s going to be a big space for these apps.
[GP16]
Another barrier was a lack of knowledge of prescribable apps
and a lack of trustworthy sources to access them.
Probably the only other barrier is knowing which
apps. And keeping on top of all the apps they become
available, how much they cost and all those kinds of
things. [GP20]
I do. I think it’s something I’m cautious of simply
because if it’s not something that I know a lot about
then I’m a bit more concerned, you know, I don’t
really wanna recommend something I don’t know the
full workings of, especially if I’m gonna ask them to
buy. There’s so much of me asking them to go on
medication until I’m confident that money is money
worth spent and the benefit outweighs the cost, then
I’m not really willing to do that. [GP2]
I think for education it’s really valuable. Ones that I
don’t use enough of and they all want more
information. Otherwise, they’ll just Google some
unreliable search, and so if I’ve got a good place to
go to that’s evidence-based, that’s good. [GP18]
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Another barrier was the time commitment required to learn
about apps and integrating them into consultations as well as
the time commitment required of the patients to use the
recommended app. Before they were willing to expend time to
adopt apps into their clinical practice, GPs described needing
to be convinced of the benefits of using apps.
And it’s time-consuming to learn about these things.
It’s hard enough just keeping up with what medicine
is doing without this app and that app etc. [GP1]
You’re so busy doing in medicine there’s not a lot of
time to go out there and research what might need to
be done to create an app or even the ones that are
out there. We’re so rushed for time. You’re competing
with lots of other demands for your time and energy
as well. So that’s a big limiting factor. [GP8]
The patients’ motivation would be a big thing. And
the time involved in using it would be another big
thing for someone who might be busy, for example. I
don’t think a lot of people have a lot of time to invest
in this type of thing. So, I think your time, availability,
and the motivation behind a patient. [GP15]
I think for me, it’s just when you are consulting, and
you’re busy. To modify the practice of what I’m doing,
I have to have a pretty good reason for doing it. [GP6]
Another barrier identified was the privacy, safety, and
trustworthiness of health apps. The GPs perceived issues around
privacy and data safety of health apps as the ultimate
responsibility of the patients, since their complete and ongoing
safety cannot be guaranteed. Some GPs were aware of how the
industry attempts to influence health care.
I personally manage my privacy very, very, very
carefully. But I think I leave that to the individual
patient... and I think that if they’re going to be using
apps, my perception is that they already have made
their own personal decisions upon privacy. [GP4]
I think that’s every day now. I mean the number of
times you get on Google and then they already go
okay well you’ve got this many children, and I know
that already… that’s the world we live in. I don’t think
we’re going to stop that by not using an app when
we’re on the internet all the time. So, if it’s
demographic information and I think that’s being
collected by a lot of people, not just an app, I suppose.
[GP20]
Also, I guess I’m also very wary of who’s paying for
it. So, I guess my general approach to most things is
to think if you’re going to pay for it, then hopefully
you are bearing the load of what if it’s worth it. If
someone else is paying then there’s some hidden
agenda there, whether it’s a drug company or
someone else who’s gonna benefit of you having their
app on your phone and again that comes down to my
reticence to recommend something I really don’t know
who’s designed it and what’s the purpose of it and
who’s benefiting the most. [GP2]
Facilitators
We identified two main themes around facilitators of mHealth
app prescription in general practice. One was a trustworthy
source for prescribable apps and information for GPs. The
RACGP was the most preferred trustworthy source to vet,
endorse, and provide prescribable apps as the majority of the
GPs were RACGP members.
Maybe some sort of database of trusted apps that
would be recommended for certain conditions or
treatment strategies. Having a nice little summary of
things that could be used, because of the sheer number
of what’s on the market, it’s hard to really make it
part of my regular day-to-day routine... Whereas if
some organization was to put together a list of you
know tried and tested and reliable apps then it would
be much easier to say “look, you’re young you’ll
you've got the time and the patience for it, let's try an
app for this problem, and this is the one we trust.
[GP15]
I think we probably need to have them reliably
approved and researched by our college. I probably
wouldn’t be happy to recommend any without the
endorsement of the college. [GP11]
We need more education on which ones to prescribe
and which ones not. We have the NPS which helps us
with prescribing medications. So, if there were an
organization/body involved with educating GPs on
which apps are good and useful and provide the right
information and are easy to use, that would be really
helpful. [GP16]
GPs recognized that near-universal ownership of smartphones,
the ubiquity of apps, and younger tech-savvy patients are
enablers of app prescription, as this facilitates information
accessibility and can sometimes provide alternatives that are
more convenient and lower in cost.
I work in an area where there's a lot of young people,
and most of these people are … generally pretty
switched on. and … I can't imagine a situation where
I’m not being able to recommend an app so somebody.
This hasn't happened yet. [GP12]
Apps are quite a neat way of showing somebody all
that information without having a book to give them.
It's often a very low-cost solution if your alternatives
are costly. And it's very accessible... you don't need
to wait for in-hours care, you can be 10 p.m. at night
and do some of the work, whether it's treatment or
information and knowledge that you're sharing that
can all be done at a time that suits a patient. so that's
the kind of value of apps I suppose over other
resources. [GP20]
Patient Perspective
Two-thirds of the patients have used or use mHealth apps
personally. The most commonly used app types were fitness,
wellness, and women’s health-related apps (period, ovulation,
and pregnancy tracking). Those who did not use apps said the
reason was they do not have any need or significant reason to
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do so. People often chose apps through the recommendations
of friends or family, directly from app stores, or through
subscribed services such as the local gym. From the list of
popular and evidence-based apps, they recognized some of the
most popular apps, such as MyFitnessPal and 5K runner, but
none of the evidence-based apps.
Barriers
From the patients’ perspective, a perceived barrier to using
mHealth apps in general practice consultations was older
patients.
I don’t think there’d be any problem. But if we’re
talking about the elderly, they’re not really very
computer-savvy. So, they might find it difficult. I have
a number of friends, even older than me; they don’t
wanna use smartphones. It’s too much trouble. They
just wanna make a phone call and get a text. That’s
it. [Pt8]
I guess only with the older generation not having
smartphones. They would not use apps. So that would
really be the only problem. Yeah, I wouldn’t see any
other [issue]. [P2]
Another barrier was poor usability of apps.
I think the ease-of-use has to be paramount. Ease of
use is gotta be the big issue. For me, that was the
problem. I can’t speak for other people. I mean I’m
pretty good with technology, but I just found it very
tedious… And I just found it was annoying to put data
in. That was the issue with it. So, when it becomes
difficult, I didn’t do it. [Pt12]
Data safety and privacy issues related to health app use were
not a barrier described by the patients interviewed. Patients were
more concerned about the loss of financial information than
health-related information.
I don’t worry about it too much, privacy stuff, cause
I don’t have much to hide. Maybe if someone got on
to your phone, they could see your personal
information, they usually have like a passcode for
private apps anyway. [P13]
Me personally, no. data safety… it is what it is. I think
there are measures in place to keep it safe. Other
people probably don’t have that opinion. I think
honestly it is safe enough. [P15]
I’m more worried about financial stuff than health
that would create a financial loss. if somebody finds
out what my blood pressure is, what’s the big deal,
right? [Pt8]
I don’t worry about it. well, I’m not really putting
anything into an app that is that [important]… I mean
I don’t know who else in the world cares the day my
period came or how big the baby is, I haven’t really
put in banking details or anything. I haven’t used any
paid apps. [Pt6]
Facilitators
From the patients’perspective, the ubiquity of smartphones and
apps and young patients were perceived as facilitators of app
prescription.
I imagine younger people wouldn’t have any
problems. [Pt11]
I think it’s quite a common thing now. Everyone has
smartphones nowadays. So, it’s an easy way to access
it. [Pt1]
Most patients expressed that they think mHealth apps can be
beneficial, especially when recommended by their doctor and
that app prescription by GPs is possible, helpful, and welcome
because it would eliminate the challenge of finding health apps
for themselves.
Great idea if they’re prescribed from a doctor. I don’t
think getting them off the net without advice would
be a good thing. I think it needs to be advised or
prescribed by someone who knows, and then from
there, it can only be a good thing, yeah. [Pt15]
Yeah. If my doctor recommended one, I’d probably
go with that rather than trying to go from the
recommendations on iPhone, you know, the stars,
from the app stores. I mean, they are helpful too what
other users have found, cause a lot of apps crash and
have problems if they’re not maintained and
upgraded, but yeah, if a doctor was recommending
one, I’d probably use it. [Pt9]
If there are multiple people being like, “this is really
good. This has helped me with this…” then I’ll
actually go have a look. If I like it for more than a
week, then I’ll just continue using it. I went through
a lot [of apps] before finding the one that wasn’t an
effort to use, one that was just easy. I went through
probably ten to find one I actually liked, which is a
bit annoying. It kind of turns you off that. So, if there
was one or two that all doctors recommended, then
people would probably more likely to use them. [Pt1]
A theme identified from both the GPs and patient perspectives
that could not be categorized as a barrier or facilitator was
evidence of app effectiveness. GPs expressed they would not
want to prescribe apps not supported by evidence, yet they also
feel that simple apps do not need high levels of evidence.
…as it applies to anything in medicine, I think it
would need a reasonable degree of efficacy to run
with it. You know, you can’t just have an app for the
sake of having an app. [GP1]
… [evidence is] pretty important to officially
recommend. Some of it is common sense. Like
something to log your blood pressure and mood diary
is self-explanatory and makes sense. But for some
more complex health apps, you sort of wanna know
if there’s good evidence so that it’s reasonably well
made. Especially if you’re going to spend money on
it. [GP14]
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Most patients viewed the evidence of app effectiveness to be
important in the same way as the standards required of
pharmaceutical interventions. Some were not concerned about
the effectiveness and preferred personal evaluations and the
freedom to make the ultimate decision.
Very important. It’s like anything in health; it’s like
medication, if a doctor is gonna recommend
something, they have to know it works. Cause it might
not be suitable for somebody, and if that person is to
use something that’s not suitable, then that could have
a bad effect instead of a good one. [Pt13]
Definitely, yea. I would want one that has references,
the app that I use have medical references they’ve
sourced the information. Otherwise, anyone could be
sitting home and writing an app. [Pt6]
I’m not too worried about that. I just get on and try
it, if it works for me then that’s great. If it doesn’t,
then I’ll just delete it if it’s not gonna do what I
needed it to do for me… I mean, as long as it’s our
choice to use them or not. I mean up to us, they can
make a recommendation, but if we find it’s not
suitable or it doesn’t work, and if it does then great
if it makes our life easier, it’s a fast and busy world,
so if they think it can help, it’s great. [Pt10]
Discussion
In this study of the barriers to and facilitators of mHealth app
prescription in Australian general practice, all patients and GPs
recognized that mHealth apps could be beneficial, and app
prescription is achievable. From the GPs’ perspective, uptake
is hindered by barriers around a generational difference in the
digital propensity for both GPs and patients, lack of knowledge
of prescribable apps and lack of trustworthy source to access
them, time commitments required of the GPs and patients, and
privacy, safety, and trustworthiness of health apps.
Both patients and GPs cited the old age of patients as a barrier
to app prescription, although also offered examples of exceptions
to this age-related division of digital propensity. Annual mobile
consumer surveys showing that older age groups have seen the
highest increase in smartphone ownership in Australia [19].
Doctors and patients also believed that the ubiquity of
smartphones and apps, and young patients are facilitating factors
as Australians approach “peak smartphone”—the peak level of
usage before the vast majority of consumers to begin actively
limiting their phone use [20]. Almost all the interviewed GPs
reported using apps personally and professionally; however,
they do not recommend specific apps to patients. Instead, they
remind patients of the availability of mHealth apps in the general
area of focus (eg, mindfulness) should they wish to use them.
The evidence base (weak or strong) for mHealth apps emerged
as an important theme as a barrier or facilitator. Patients viewed
doctors as a trustworthy source of health apps, and the GPs
acknowledged that they needed a trustworthy source for
prescribable apps as they have neither the knowledge nor time
to find such apps themselves. A national-level professional
organization such as the RACGP is well-placed to address this
barrier. One of the many resources they provide for GPs is
HANDI—a database of effective nondrug interventions, which
includes several mHealth apps [18]. However, half of the GPs
interviewed in this study were not familiar with or commonly
used HANDI, but all agreed that RACGP is the most trusted
source for them to access professional and practice-related
information and guidance. The majority of participants
recognized a few of the most popular apps from app stores and
fewer apps from the evidence-based apps list, emphasizing the
need for information dissemination about evidence-based apps.
Several comparable studies have explored barriers and
facilitators to novel technology adoption in medical practice.
Many studies report a lack of education and training as one of
the most common barriers that face health care providers in
adopting new technology in health care [13,21,22], and our
study echoes this. Furthermore, the potential to increase doctors’
time strain and workload are universally common factors of
poor uptake of new health technologies [23-25]. Brandt et al
found that the experiences of GPs with eHealth support for
lifestyle changes were an essential factor in recommending it
for their patients [26]. Our findings also emphasize the digital
propensity of the health care providers and patients would make
a big difference in uptake of mHealth apps. Building on this
finding and educating and supporting GPs so they understand
the value of new technology such as the potential to save
consultation time and keep patients connected and motivated
between consultations can help mitigate against these barriers
and help them recommend apps to their patients with confidence.
Recent research suggests that individuals with poor self-reported
health and low rates of physical activity were the least likely to
report downloading and using these health tools [27]; however,
patients adhere better to prescribed apps [2] beyond the typical
one week of usage [4,5]. Thus, the official prescription of apps
by trusted medical practitioners might help increase the uptake
of effective health apps among such patients who would benefit
the most. Future studies should measure the real-world
adherence of the patients following app prescription by health
professionals.
The present qualitative study appears to be the first of its kind
to explore the perspectives of GPs and patients regarding
mHealth app prescription in Australian general practice. The
barriers identified in this study were added to the mHealth
section of the RACGP Annual Technology survey in 2017 to
explore further how they would rank among a national sample
of GPs [28]. The question about barriers to app prescription
gathered over six hundred responses and the top barriers
reflected the central theme identified in this study, which was
lack of knowledge of effective apps and lack of trustworthy
source to access them, further validating the findings of this
study.
Limitations of this study include a small sample size that skewed
towards relatively healthy patients from high socioeconomic
areas and GPs from the metropolitan area. Although we
attempted to mitigate this limitation by purposively sampling
participants from a variety of age and work experience, future
studies should target patients with long-term medical conditions,
those from rural and remote areas, and low socioeconomic areas.
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Other limitations include lack of triangulation of the results,
member checking, a reflection of possible interviewer bias about
the potential of apps, and not piloting the interview questions
with patients.
Conclusions
mHealth app prescription appears to be feasible in general
practice. The barriers and facilitators we identified from both
GPs and patients widely overlapped. The involvement of all
stakeholders of consumer mobile technology, medical
professionals, and patients is vital in the successful integration
of mHealth apps with clinical practice. The findings of this
study will inform the development of effective interventions to
overcome the identified barriers and help the adoption of health
apps to general practice to patients’ benefit.
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